Announcement

Collapse
No announcement yet.

Idaho - Outbreak of fungal meningitis and associated infections - 1 case

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Idaho - Outbreak of fungal meningitis and associated infections - 1 case

    Eastern Idaho Man Diagnosed with Fungal Meningitis



    posted on October 10, 2012 13:37
    Illness is Believed Linked to National Recall
    An eastern Idaho man over the age of 60 who received an epidural steroid injection in September has been diagnosed with non-contagious fungal meningitis that is believed to be associated with a national outbreak being investigated by the Centers for Disease Control and Prevention. This is the first illness in Idaho linked to the steroid injections. The man is being treated for his illness, but because of HIPAA privacy laws, updates on the man’s medical condition cannot be made public.



    Nationally, including the Idaho case, an estimated 138 people from 11 states have become ill with fungal meningitis that is linked to the investigation, with 12 deaths reported. The epidural steroid injections are generally used for people with back pain. All infected patients received an injection with preservative-free methylprednisolone acetate prepared by New England Compounding Center in Framingham, Mass. The New England Compounding Center has been closed, with all of its products being recalled or withheld from use. Seventy-six facilities from 23 states received shipments of the potentially contaminated epidural injections being investigated.



    Two Idaho facilities received shipments of the recalled injections -- Walter Knox Memorial Hospital in Emmett, and Pain Specialists of Idaho in Idaho Falls. From the initial investigation, four people received injections from Walter Knox, while the Idaho Falls pain clinic treated 35 people. Both Idaho facilities received shipments of the recalled injections after July 1. Nationally, the CDC estimates 13,000 people received epidural injections from possibly contaminated steroids.
    “We are very concerned for this patient and are working closely with his physicians,” says Idaho State Epidemiologist Dr. Christine Hahn, M.D. “We urge patients who received injections from either of these facilities to maintain close contact with their medical providers and notify them if any new symptoms develop over the next few weeks.”
    Symptoms may include a new or worsening headache, dizziness, fever, nausea, and sensitivity to light. A number of people who became ill also had symptoms of stroke, such as weakness or difficulty with speech. Most of the illnesses are being reported one to four weeks after the injection was received. Fungal meningitis is not transmitted from person to person.
    We will provide updates as new information becomes available. For additional information and up-to-date national case counts, please visit the Centers for Disease Control and Prevention website at: http://www.cdc.gov/HAI/outbreaks/meningitis.html
    Contact:
    Tom Shanahan
    Public Information Officer
    (208) 334-0668



    http://www.healthandwelfare.idaho.go...eningitis.aspx

  • #2
    Re: Idaho - Outbreak of fungal meningitis - 1 case

    Health officials contact Idaho clinics about possible infections related to expanded meningitis investigation

    posted on October 16, 2012 16:47

    The Idaho Division of Public Health is contacting nine Idaho medical facilities that may have received injectable drugs from New England Compounding Center (NECC) since May 2012 that could pose a potential risk for infection or meningitis. The nine clinics are being urged to contact their patients who may have received injections to make certain they do not have symptoms of infection and to report any new symptoms.

    The Food and Drug Administration (FDA) expanded its investigation of possibly contaminated pharmaceuticals produced by NECC beyond the epidural steroids already recalled. The expanded list includes NECC injectable drugs distributed since May 2012 for joint pain, and also used during heart and eye surgeries. At this time, no illnesses associated with the expanded list of NECC injectable drugs have been confirmed. Idaho Public Health will identify the nine Idaho facilities after it verifies each facility received and used the NECC products. It is not known at this time how many patients may be affected.

    In late September, a NECC epidural steroid commonly used for back pain was tied to a fungal meningitis outbreak being investigated by the Centers for Disease Control and Prevention. Twenty-three states received shipments of the NECC epidural product, including two facilities in Idaho. Those are Walter Knox Memorial Hospital in Emmett, and Pain Specialists of Idaho in Idaho Falls. With these two facilities, a total of 11 Idaho medical providers may have received and used NECC injectable products since May 2012.

    One eastern Idaho resident over the age of 60 is being treated for fungal meningitis that is tied to the outbreak. He is currently hospitalized and responding well to treatment. Nationally, 233 illnesses are being investigated, including 15 deaths.

    For additional information about the CDC investigation, please visit: http://www.cdc.gov/HAI/outbreaks/meningitis.html
    Contact:
    Tom Shanahan
    Public Information Manager
    (208) 334-0668

    http://healthandwelfare.idaho.gov/Ab...stigation.aspx
    "Safety and security don't just happen, they are the result of collective consensus and public investment. We owe our children, the most vulnerable citizens in our society, a life free of violence and fear."
    -Nelson Mandela

    Comment

    Working...
    X